Baloxavir Exhibits Antibacterial Activity Against Staphylococcus aureus by Inhibiting De Novo Purine Biosynthesis

Xue Li1,2,3, Yan Yang4, Penghe Wang1,2

  • 1Beijing Key Laboratory of Technology and Application for Anti-Infective New Drugs Research and Development, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.

Insights

The influenza antiviral baloxavir shows potent antibacterial activity against Staphylococcus aureus, including MRSA. This repurposed drug effectively treats persistent intracellular infections and improves survival rates in mouse models.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Drug Repurposing

Background:

  • Staphylococcus aureus (S. aureus) is a major global health concern, causing significant morbidity and mortality.
  • Persistent and relapsing S. aureus infections present a substantial challenge.
  • There is a need for novel therapeutic strategies against antibiotic-resistant strains like MRSA.

Purpose of the Study:

  • To investigate the antibacterial activity of baloxavir, an influenza antiviral, against S. aureus.
  • To evaluate baloxavir's efficacy in treating intracellular S. aureus infections.
  • To explore the potential of baloxavir as a repurposed drug for S. aureus infections.

Main Methods:

  • In vitro susceptibility testing (MICs) and time-kill assays against MSSA and MRSA.
  • Intracellular S. aureus killing assays in A549 epithelial cells and RAW264.7 macrophages.
  • In vivo efficacy studies in a mouse model of MRSA infection.
  • Transcriptomic analysis to identify molecular mechanisms of action.

Main Results:

  • Baloxavir demonstrated potent activity against MSSA and MRSA (MICs 2-4 μg/mL).
  • Concentration-dependent killing of S. aureus was observed in time-kill assays.
  • Baloxavir effectively reduced intracellular S. aureus in cell lines and improved survival in a mouse model.
  • Downregulation of purine de novo biosynthesis genes (purF, purK) was identified as a key mechanism.

Conclusions:

  • Baloxavir exhibits significant antibacterial activity against S. aureus, including MRSA.
  • The drug is effective against intracellular S. aureus and shows promise in vivo.
  • Baloxavir represents a potential repurposed therapeutic candidate for persistent S. aureus infections.
  • The mechanism involves the downregulation of purine biosynthesis pathways.

Related Concept Videos

Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...